Genomtec S.A. (WSE:GMT)

Market Cap	101.27M
Revenue (ttm)	1,000.00
Net Income (ttm)	-11.58M
Shares Out	13.32M
EPS (ttm)	-0.87
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,303
Average Volume	28,365
Open	7.59
Previous Close	7.60
Day's Range	7.36 - 7.70
52-Week Range	6.50 - 13.04
Beta	0.24
RSI	50.99
Earnings Date	May 29, 2025

About Genomtec

Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and othe...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 17
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: GMT

Financial Performance

In 2023, Genomtec's revenue was 1,000, a decrease of -97.50% compared to the previous year's 40,000. Losses were -9.01 million, -24.44% less than in 2022.